Contract notice
Section I: Contracting
authority
I.1) Name and addresses
University of Leeds
Worsley building L11, Level 11 Worsley Building, Clarendon Way
Leeds
LS2 9JZ
UK
Contact person: Fiona Coleman
Telephone: +44 1133434339
E-mail: f.coleman@leeds.ac.uk
NUTS: UKE42
Internet address(es)
Main address: https://www.leeds.ac.uk/
I.2) Joint procurement
The contract is awarded by a central purchasing body
I.3) Communication
The procurement documents are available for unrestricted and full direct access, free of charge at:
https://www.delta-esourcing.com/tenders/UK-UK-Leeds:-Pharmaceutical-products./KN99DX49U3
Additional information can be obtained from the abovementioned address
Tenders or requests to participate must be sent electronically to:
https://www.delta-esourcing.com/tenders/UK-UK-Leeds:-Pharmaceutical-products./KN99DX49U3
Tenders or requests to participate must be sent to the abovementioned address
I.4) Type of the contracting authority
Body governed by public law
I.5) Main activity
Education
Section II: Object
II.1) Scope of the procurement
II.1.1) Title
Storage, Distribution and Labelling of Drugs for Clinical Trials
Reference number: 2023-24-3489
II.1.2) Main CPV code
33600000
II.1.3) Type of contract
Supplies
II.1.4) Short description
The Leeds Institute of Clinical Research at the University of Leeds (UoL) is seeking tenders for a supplier for the Storage, Distribution and Labelling of Drugs for Clinical Trials
This tender is made up of 3 Lots for 3 different trials
II.1.5) Estimated total value
Value excluding VAT:
250 000.00
GBP
II.1.6) Information about lots
This contract is divided into lots:
Yes
Tenders may be submitted for all lots
Maximum number of lots that may be awarded to one tenderer: 3
II.2) Description
Lot No: 1
II.2.1) Title
Lot 1 (Trial 1) – SPECTRUM
II.2.2) Additional CPV code(s)
33600000
II.2.3) Place of performance
NUTS code:
UKE42
Main site or place of performance:
Leeds
II.2.4) Description of the procurement
This trial is subject is currently awaiting a funding award based on the funding application. The outcome of this tender will be part of the final application as we are required to demonstrate that we have sought to provide the best value for money to the funding body.
The estimated start date for this trial is Q1 2025.
II.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6) Estimated value
Value excluding VAT:
50 000.00
GBP
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 22
This contract is subject to renewal: No
II.2.9) Information about the limits on the number of candidates to be invited
Envisaged minimum number: 2
II.2.10) Information about variants
Variants will be accepted:
No
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Lot No: 2
II.2.1) Title
Lot 2 (Trial 2) – IMMERSE
II.2.2) Additional CPV code(s)
33600000
II.2.3) Place of performance
NUTS code:
UKE42
Main site or place of performance:
Leeds
II.2.4) Description of the procurement
The estimated start date for this trial is Dec 2024.
It is anticipated that 30 patients will be recruited to this trial over a period of 12 months (depending on patient recruitment rates) and patients will remain on treatment for a maximum of 36 months.
II.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6) Estimated value
Value excluding VAT:
200 000.00
GBP
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 48
This contract is subject to renewal: No
II.2.9) Information about the limits on the number of candidates to be invited
Envisaged minimum number: 2
II.2.10) Information about variants
Variants will be accepted:
No
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Lot No: 3
II.2.1) Title
Lot 3 (Trial 3) – BITTEN
II.2.2) Additional CPV code(s)
33600000
II.2.3) Place of performance
NUTS code:
UKE42
Main site or place of performance:
Leeds
II.2.4) Description of the procurement
This trial is subject is currently awaiting a funding award based on the funding application. The outcome of this tender will be part of the final application as we are required to demonstrate that we have sought to provide the best value for money to the funding body.
The estimated start date for this trial is Summer 2025.
It is anticipated that 40 patients will be recruited to this trial over a period of 18 months (depending on patient recruitment rates) and patients will remain on treatment for a maximum of 12 months.
II.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6) Estimated value
Value excluding VAT:
200 000.00
GBP
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 36
This contract is subject to renewal: No
II.2.9) Information about the limits on the number of candidates to be invited
Envisaged minimum number: 2
II.2.10) Information about variants
Variants will be accepted:
No
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure
Competitive procedure with negotiation
IV.1.4) Information about reduction of the number of solutions or tenders during negotiation or dialogue
Recourse to staged procedure to gradually reduce the number of solutions to be discussed or tenders to be negotiated
IV.1.8) Information about Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement:
Yes
IV.2) Administrative information
IV.2.2) Time limit for receipt of tenders or requests to participate
Date:
08/04/2024
Local time: 10:00
IV.2.4) Languages in which tenders or requests to participate may be submitted
EN
IV.2.6) Minimum time frame during which the tenderer must maintain the tender
Duration in months: 3 (from the date stated for receipt of tender)
Section VI: Complementary information
VI.1) Information about recurrence
This is a recurrent procurement:
No
VI.3) Additional information
For more information about this opportunity, please visit the Delta eSourcing portal at:
<a href="https://www.delta-esourcing.com/tenders/UK-UK-Leeds:-Pharmaceutical-products./KN99DX49U3" target="_blank">https://www.delta-esourcing.com/tenders/UK-UK-Leeds:-Pharmaceutical-products./KN99DX49U3</a>
To respond to this opportunity, please click here:
<a href="https://www.delta-esourcing.com/respond/KN99DX49U3" target="_blank">https://www.delta-esourcing.com/respond/KN99DX49U3</a>
GO Reference: GO-2024226-PRO-25364687
VI.4) Procedures for review
VI.4.1) Review body
The High Court of England and Wales
The Strand, 1 - 3 Lifton Villas, Lifton Place
London
WC2A 2LL
UK
VI.4.2) Body responsible for mediation procedures
University of Leeds
Purchasing Office, Level 11 Worsley Building, Clarendon Way
Leeds
LS2 9JT
UK
E-mail: centralpurchasing@adm.leeds.ac.uk
VI.4.4) Service from which information about the review procedure may be obtained
University of Leeds
Purchasing Office, Level 11 Worsley Building, Clarendon Way
Leeds
LS2 9JT
UK
E-mail: centralpurchasing@adm.leeds.ac.uk
VI.5) Date of dispatch of this notice
26/02/2024